Sultiame (or sulthiame) is a sulfonamide and inhibitor of the enzyme carbonic anhydrase. It is used as an anticonvulsant and in recent studies showed promise in reducing sleep disordered …

Apr 7, 2022 · In the current four-week, randomized, placebo-controlled, double-blind trial, the investigators observed that those taking sulthiame experienced a clinically relevant OSA …

Sultiame is a carbonic anhydrase inhibitor that has been used as an antiepileptic agent in most forms of epilepsy except absence seizures. It may act by lowering the neuronal intracellular …

Sep 15, 2010 · Sulthiame is a carbonic anhydrase inhibitor used primarily in benign focal epilepsies of childhood that may be useful as an adjunct therapy in a variety of other refractory …

FRIDAY, Sept. 13, 2024 -- Sulthiame (STM) is beneficial for improving symptoms of obstructive sleep apnea (OSA), according to a study presented at the European Respiratory Society …

In this review, we have presented a summary of evidence for the use of STM as monotherapy in epilepsy. To assess the efficacy and side effect profile of STM as monotherapy when …

Jan 7, 2025 · Sultiame is a carbonic anhydrase inhibitor used primarily in benign focal epilepsies of childhood that may be useful as an adjunct therapy in a variety of other refractory …

Sep 1, 2016 · We report the efficacy of sultiame in treating three children with drug-resistant absence seizures and discuss the potential use of sultiame beyond the idiopathic focal …

Sulthiame, also known as sultiame, is a widely used antiepileptic drug in Europe and Israel. We present a summary of the evidence for the use of sulthiame as add‐on therapy in epilepsy. …

Jan 7, 2025 · Sulthiame is a carbonic anhydrase inhibitor used primarily in benign focal epilepsies of childhood that may be useful as an adjunct therapy in a variety of other refractory …